| Recruiting | Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Mal Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia, Myelodysplastic Syndromes (MDS) | Phase 2 | 2025-05-10 |
| Recruiting | Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL Hodgkin Lymphoma | Phase 2 | 2024-10-14 |
| Recruiting | PD-1 Inhibitors Maintenance for cHL Post-autoHCT Hodgkin Lymphoma | Phase 2 | 2024-09-02 |
| Enrolling By Invitation | Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma Primary Mediastinal (Thymic) Large B-cell Lymphoma, Children, Nivolumab | Phase 1 / Phase 2 | 2024-09-01 |
| Recruiting | BeFluBu vs FluBuRux Conditioning in Haploidentical HCT Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia | Phase 2 | 2024-06-21 |
| Recruiting | Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndromes, Chronic Myeloid Leukemia | Phase 2 | 2024-05-22 |
| Recruiting | Vitamin A and D Supplementation in Allogeneic HCT Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia | Phase 2 | 2024-05-15 |
| Unknown | Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma Hodgkin Lymphoma | Phase 2 | 2023-04-19 |
| Unknown | The Impact of the "Stone MD" Mobile App on the Prevention of Forgotten Ureteral Stents Urolithiasis | N/A | 2023-02-01 |
| Unknown | Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy. Kidney Stone | N/A | 2022-10-17 |
| Enrolling By Invitation | Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Relapsed or Refractory Hodgkin Lymphoma, Children, Nivolumab | Phase 2 | 2022-06-01 |
| Completed | Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy Hematologic Malignancy | Phase 1 / Phase 2 | 2021-04-01 |
| Completed | Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease Ocular Graft-versus-host Disease | Phase 2 | 2021-04-01 |
| Unknown | A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Ca Hodgkin Lymphoma | Phase 1 / Phase 2 | 2021-03-01 |
| Completed | Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | 2021-01-21 |
| Completed | Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia | Phase 2 | 2021-01-21 |
| Unknown | Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2020-12-21 |
| Completed | PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia | Phase 2 | 2020-11-03 |
| Recruiting | AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2020-10-01 |
| Unknown | The Effects of Oxiris on Systemic Inflammation and Endothelial dysFunction Acute Kidney Injury Due to Circulatory Failure (Disorder) | N/A | 2020-08-17 |
| Completed | Safety and Effectiveness of Ureteral DJ Stent With Magnet (Blackstar, Urotech) Removal Under Ultrasound Contro Urolithiasis | N/A | 2020-08-14 |
| Unknown | Bladder Catheterization After Mini-PCNL Urolithiasis | N/A | 2020-07-01 |
| Unknown | The Use of Direct Puncture Technique With Mini-PCNL Urolithiasis | N/A | 2020-07-01 |
| Completed | Mixed Reality Technology in Laparoscopic Partial Nephrectomy Kidney Tumor | N/A | 2020-06-01 |
| Recruiting | Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric C Peritoneal Carcinomatosis, Gastric Cancer | N/A | 2020-02-10 |
| Completed | Effects of Parenteral Nutrition in HSCT Hematologic Malignancy | N/A | 2020-02-01 |
| Terminated | Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intesti Intestinal GVHD | Phase 1 / Phase 2 | 2019-09-01 |
| Terminated | Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2019-06-01 |
| Unknown | Evaluation of Outcomes of Coronary Artery Bypass Grafting. Ischemic Heart Disease, Coronary Artery Bypass Grafting | N/A | 2018-12-20 |
| Unknown | Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures. Cardiac Procedure Complication, Ischemic Heart Disease, Valve Heart Disease | N/A | 2018-12-20 |
| Completed | OPTIMAL STENTS DURING RENAL COLIC Ureteral Stent Occlusion | N/A | 2018-06-01 |
| Recruiting | Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy Membranous Nephropathy - PLA2R Induced | N/A | 2018-05-01 |
| Completed | SEARCH FOR OPTIMAL ANAESTHESIA IN RETROGRADE INTRARENAL SURGERY Kidney Stone | N/A | 2017-11-01 |
| Completed | Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lympho Hodgkin Lymphoma | Phase 1 / Phase 2 | 2017-08-01 |
| Terminated | Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients Acute Myeloid Leukemia | Phase 2 | 2017-06-30 |
| Completed | A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Hodgkin's Lymphoma | Phase 1 / Phase 2 | 2017-05-27 |
| Terminated | Nivolumab With Chemotherapy in Refractory MDS Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2017-05-25 |
| Active Not Recruiting | ASCT With Nivolumab in Patients With Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2017-04-24 |
| Completed | Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | 2017-03-27 |
| Completed | Ruxolitinib for Steroid-refractory GVHD Graft Vs Host Disease | Phase 2 | 2016-08-01 |
| Completed | GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias | Phase 1 / Phase 2 | 2016-06-01 |
| Completed | PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis Primary Myelofibrosis, Myeloproliferative Disorders | Phase 1 / Phase 2 | 2016-01-01 |
| Completed | Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG Ischemic Heart Disease, Coronary Artery Disease, Ischemic Reperfusion Injury | — | 2015-09-15 |
| Unknown | The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation Stroke, AMI, Total Hip Replacement | — | 2015-09-01 |
| Terminated | Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | Phase 2 | 2015-07-01 |
| Recruiting | Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy Primary IgA-nephropathy, High-risk, Caucasians | N/A | 2013-03-10 |
| Completed | Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease Ischemic Heart Disease, Bone Marrow Cells, Coronary Artery Bypass Grafting (CABG) | N/A | 2013-02-01 |
| Unknown | Clinical and Laboratory Biomarkers in Patients With Atherothrombotic Stroke Carotid Artery Diseases, Stroke | — | 2011-01-01 |
| Completed | Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome Topiramate, Lamotrigine, Memnatine | N/A | — |